Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2, 4‐dione derivatives as VEGFR‐2 inhibitors

K El‐Adl, H Sakr, SSA El‐Hddad… - Archiv der …, 2021 - Wiley Online Library
The anticancer activity of novel thiazolidine‐2, 4‐diones was evaluated against HepG2, HCT‐
116, and MCF‐7 cells. Among the tested cancer cell lines, HCT‐116 was the most sensitive …

Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2, 4-dione derivatives as VEGFR-2 inhibitors

K El-Adl, H Sakr, SSA El-Hddad… - Archiv der …, 2021 - pubmed.ncbi.nlm.nih.gov
The anticancer activity of novel thiazolidine-2, 4-diones was evaluated against HepG2, HCT-
116, and MCF-7 cells. Among the tested cancer cell lines, HCT-116 was the most sensitive …

Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2, 4-dione derivatives as VEGFR-2 inhibitors.

K El-Adl, H Sakr, SSA El-Hddad, AA El-Helby… - Archiv der …, 2021 - europepmc.org
The anticancer activity of novel thiazolidine-2, 4-diones was evaluated against HepG2, HCT-
116, and MCF-7 cells. Among the tested cancer cell lines, HCT-116 was the most sensitive …